Dabigatran etexilate for the treatment of acute venous thromboembolic events
| Status: |
In progress |
| Expected date of issue: |
TBC |
| Referral date: |
July 2009 |
| Wave: |
21 |
| Process: |
STA |
| Topic area:
|
NICE project team
| Executive Lead: |
TBC
|
| Technical Lead: |
TBC
|
| Communications manager: |
TBC
|
| Project manager: |
TBC
|
Provisional schedule
| Closing date for invited submissions / evidence submission: |
TBC |
| 1st appraisal committee meeting: |
TBC |
Consultees and commentators
Project history
| Date |
Summary |
| 3 December 2010 |
Following on from information received from the manufacturer, dates for this appraisal will be confirmed once regulatory approval timelines are established. |
| 5 November 2009 |
Please note that following on from advice received from the manufacturer, this appraisal has been rescheduled to align with latest regulatory expectations. Therefore, we now anticipate that the appraisal will begin during mid April 2011. The deadline for submissions is expected in approximately late June 2011. |
| 15 December 2010 |
Following on from advice received from the manufacturer, dates for this appraisal will be confirmed once regulatory approval timelines are established. |
|
Key documents
This page was last updated: 15 December 2010
